OutSee logo — AI genomics

OutSee

AI genomics

Founded 2023 United Kingdom Cambridge, United Kingdom 10 employees Seed Total: $1.80M

General Information

Company Name OutSee
Founded Year 2023
Location United Kingdom Cambridge, United Kingdom +1
Employees 10
Funding Stage Seed
Social

Get notified when OutSee moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About OutSee

OutSee, founded in 2023 and headquartered in the United Kingdom, is carving a niche in the realm of AI genomics. The company is focused on developing advanced computational approaches for genomics, with the primary aim of revolutionizing drug target discovery and precision medicine. Its promising technology leverages artificial intelligence to streamline genomic analysis, providing significant potential for advancements in the medical field.

Recently, OutSee secured a £1.80M Seed investment on 24 June 2025. This round attracted notable investors such as Ahren Innovation Capital, Kadmos Capital, Empirical Ventures, and Panacea Ventures, indicating strong market validation and confidence in the startup's vision. As OutSee continues to innovate, its strategic position in the biotech industry makes it a compelling opportunity for investors seeking exposure to cutting-edge technology in precision medicine.

Taxonomy: AI Genomics, Computational Biology, Drug Target Discovery, Precision Medicine, Genomics Innovation, Bioinformatics, AI-Driven Healthcare, Machine Learning in Genomics, Targeted Therapy Development, Genomic Data Analysis, Pharmacogenomics, Medical Algorithms, Genetic Research, Biomedical Data Science

Services & Products

Genomics Led Discovery
Predictive Disease and Phenotype Analysis
AI-based Target Discovery
Precision Medicine Solutions

Target Customers

Healthcare Researchers Pharmaceutical Companies Biotechnology Firms Genomic Research Institutions

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed •••••• 4
Investor
•••• ••••
24 Jun 2025

OutSee Alternatives & Competitors

View All Alternatives
OutSee vs
GENOME INSIGHT INC.
GENOME INSIGHT INC. United States

Cancer whole genome platform company

Series B
54 employees
Analytics, Biotechnology
OutSee vs
CURIO Genomics
CURIO Genomics United States

Ask more questions. Gain better insights. Make faster breakthroughs.

4 employees
Analytics, Big Data
OutSee vs
Open Targets
Open Targets United Kingdom

A partnership using human genetics and genomics data for systematic drug target identification and p...

21 employees
Biotechnology, Health and Wellness

FAQ About OutSee

AI genomics
OutSee was founded in 2023.
OutSee is headquartered in Cambridge, United Kingdom.
OutSee has approximately 10 employees.
OutSee has completed 1 funding round, raising a total of $1.80M. The latest funding stage is Seed.
OutSee offers: Genomics Led Discovery, Predictive Disease and Phenotype Analysis, AI-based Target Discovery, Precision Medicine Solutions.
Top alternatives and competitors to OutSee include GENOME INSIGHT INC., CURIO Genomics, Open Targets, GenomiCare Biotechnology, Nexco Analytics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
OutSee and GENOME INSIGHT INC. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors OutSee and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy